Jefferies analyst Matthew Taylor lowered the firm's price target on Medtronic (MDT) to $95 from $108 and keeps a Hold rating on the shares. The firm updated its FY26 EPS outlook to reflect MiniMed (MMED) IPO timing and one-time expenses for Minimed Flex. Jefferies added that Medtronic's announced one-time $157M charge in Q4 related to the present value of future payments owed to Blackstone for the MiniMed Flex launch added to the EPS guide revision.
